Opaleye Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-217,000
| Closed | -$5.2M | – | 41 |
|
|
2023
Q2 | $5.2M | Buy |
+217,000
| New | +$5.2M | 1.24% | 22 |
|
|
2020
Q2 | – | Sell |
-1,500
| Closed | -$63K | – | 49 |
|
|
2020
Q1 | $63K | Sell |
1,500
-205,000
| -99% | -$8.61M | 0.02% | 42 |
|
|
2019
Q4 | $8.83M | Buy |
206,500
+6,500
| +3% | +$278K | 1.73% | 26 |
|
|
2019
Q3 | $7.2M | Hold |
200,000
| – | – | 2.6% | 19 |
|
|
2019
Q2 | $5.35M | Hold |
200,000
| – | – | 1.63% | 27 |
|
|
2019
Q1 | $5.37M | Buy |
200,000
+5,000
| +3% | +$134K | 1.49% | 28 |
|
|
2018
Q4 | $3.15M | Hold |
195,000
| – | – | 1.18% | 27 |
|
|
2018
Q3 | $4.05M | Buy |
+195,000
| New | +$4.05M | 1.03% | 30 |
|